排序方式
1-25 的 36 產品與服務
The AlphaLISA® Human C1q Binding Kit is designed to monitor the binding of the IgG Fc region to the human C1q protein.
The AlphaLISA® Human XIAP BIR3 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, XIAP BIR3 domain, using Alpha Technology.
The AlphaLISA® Human XIAP BIR2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, XIAP BIR2 domain, using Alpha Technology.
The AlphaLISA® Human MDM2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, MDM2, using Alpha Technology.
The AlphaLISA® Human cIAP1 BIR3 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, cIAP1 BIR3 domain, using Alpha Technology.
The AlphaLISA® Human cIAP1 BIR2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, cIAP1 BIR2 domain, using Alpha Technology.
The AlphaLISA® Human Cereblon Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, Cereblon, using Alpha Technology.
The AlphaLISA® SARS-CoV2 ACE2/S1 Binding Kit is a protein-protein interaction assay for ACE2-Spike inhibitor selection in biochemical format using Alpha Technology.
The AlphaLISA® cyno PD-1/PD-L1 binding kit is designed for the detection of binding activity between cyno PD-1 and PD-L1, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
This kit is designed to assess binding and inhibition of human PCSK9 and LDLR, using a homogeneous AlphaLISA assay (no wash steps). This assay can facilitate the design and development of antibody therapetics using competition assays.
This is a replacement for AL3119.
The AlphaLISA® human CD28/CD86 binding kit is designed for the detection of binding activity between human CD28 and CD86, using a fast and simple homogeneous AlphaLISA assay (no wash steps). This assay can be used to screen for small molecules that inhibit binding, as a competitive ligand binding (CLB) assay to screen therapeutic blocking antibodies, and for potency assays.
1-6 的 6 技術資源